_id
6915ec2abc934aba376b1d47
Ticker
RARE
Name
Ultragenyx
Exchange
NASDAQ
Address
60 Leveroni Court, Novato, CA, United States, 94949
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.ultragenyx.com
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for the treatment of long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidates that are in Phase 3 clinical trials include UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; and GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome. It also develops UX701 that is in Phase 2 clinical trial for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; GeneTx; Mereo; University of Pennsylvania; Solid Biosciences Inc.; Regeneron; Abeona; and Arcturus Therapeutics Holdings Inc. The company was incorporated in 2010 and is headquartered in Novato, California.
Last Close
36.2
Volume
949047
Current Price
36.23
Change
0.08287292817677909
Last Updated
2025-12-03T12:43:33.203Z
Image
data:image/webp;base64,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
Ipo Date
2014-01-31T00:00:00.000Z
Market Cap
3229104384
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8957210526315791
Sentiment Sources
19
Rating
4.6
Target Price
81.85
Strong Buy
13
Buy
6
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
159933000
Cost Of Revenue
27991000
Gross Profit
131942000
Operating Expenses
302832000
Operating Income
-170890000
Interest Expense
14148000
Pretax Income
-179540000
Net Income
-180413000
Eps
-1.8082655575781479
Dividends Per Share
-
Shares Outstanding
96477569
Income Tax Expense
873000
EBITDA
-156786000
Operating Margin
-106.85099385367623
Total Other Income Expense Net
-8650000
Cash
202510000
Short Term Investments
222738000
Receivables
112543000
Inventories
52200000
Total Current Assets
643206000
Property Plant Equipment
249961000
Total Assets
1190445000
Payables
40573000
Short Term Debt
77687000
Long Term Debt
-
Total Liabilities
1174286001
Equity
9158999
Depreciation
8606000
Change In Working Capital
9735000
Cash From Operations
-91423000
Capital Expenditures
1278000
Cash From Investing
117182000
Cash From Financing
2000
Net Change In Cash
26055000
PE
-
PB
394.66257069249593
ROE
-1969.7894933714917
ROA
-15.15508906333346
FCF
-92701000
Fcf Percent
-0.5796239675364059
Piotroski FScore
1
Health Score
9
Deep Value Investing Score
2
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
159933000
Quarters > 0 > income Statement > cost Of Revenue
27991000
Quarters > 0 > income Statement > gross Profit
131942000
Quarters > 0 > income Statement > operating Expenses
302832000
Quarters > 0 > income Statement > operating Income
-170890000
Quarters > 0 > income Statement > interest Expense
14148000
Quarters > 0 > income Statement > pretax Income
-179540000
Quarters > 0 > income Statement > net Income
-180413000
Quarters > 0 > income Statement > eps
-1.8082655575781479
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
99771297
Quarters > 0 > income Statement > income Tax Expense
873000
Quarters > 0 > income Statement > EBITDA
-156786000
Quarters > 0 > income Statement > operating Margin
-106.85099385367623
Quarters > 0 > income Statement > total Other Income Expense Net
-8650000
Quarters > 0 > balance Sheet > cash
202510000
Quarters > 0 > balance Sheet > short Term Investments
222738000
Quarters > 0 > balance Sheet > receivables
112543000
Quarters > 0 > balance Sheet > inventories
52200000
Quarters > 0 > balance Sheet > total Current Assets
643206000
Quarters > 0 > balance Sheet > property Plant Equipment
249961000
Quarters > 0 > balance Sheet > total Assets
1190445000
Quarters > 0 > balance Sheet > payables
40573000
Quarters > 0 > balance Sheet > short Term Debt
77687000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1174286001
Quarters > 0 > balance Sheet > equity
9158999
Quarters > 0 > cash Flow > net Income
-180413000
Quarters > 0 > cash Flow > depreciation
8606000
Quarters > 0 > cash Flow > change In Working Capital
9735000
Quarters > 0 > cash Flow > cash From Operations
-91423000
Quarters > 0 > cash Flow > capital Expenditures
1278000
Quarters > 0 > cash Flow > cash From Investing
117182000
Quarters > 0 > cash Flow > cash From Financing
2000
Quarters > 0 > cash Flow > net Change In Cash
26055000
Quarters > 0 > ratios > PE
-1.8082655575781479
Quarters > 0 > ratios > PB
394.66257069249593
Quarters > 0 > ratios > ROE
-1969.7894933714917
Quarters > 0 > ratios > ROA
-15.15508906333346
Quarters > 0 > ratios > FCF
-92701000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.5796239675364059
Quarters > 0 > health Score
9
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
166496000
Quarters > 1 > income Statement > cost Of Revenue
23002000
Quarters > 1 > income Statement > gross Profit
143494000
Quarters > 1 > income Statement > operating Expenses
251382000
Quarters > 1 > income Statement > operating Income
-107888000
Quarters > 1 > income Statement > interest Expense
14041000
Quarters > 1 > income Statement > pretax Income
-114004000
Quarters > 1 > income Statement > net Income
-114951000
Quarters > 1 > income Statement > eps
-1.1674840592077356
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
98460445
Quarters > 1 > income Statement > income Tax Expense
947000
Quarters > 1 > income Statement > EBITDA
-91344000
Quarters > 1 > income Statement > operating Margin
-64.79915433403805
Quarters > 1 > income Statement > total Other Income Expense Net
-6116000
Quarters > 1 > balance Sheet > cash
166106000
Quarters > 1 > balance Sheet > short Term Investments
311279000
Quarters > 1 > balance Sheet > receivables
124464000
Quarters > 1 > balance Sheet > inventories
46498000
Quarters > 1 > balance Sheet > total Current Assets
719788000
Quarters > 1 > balance Sheet > property Plant Equipment
255763000
Quarters > 1 > balance Sheet > total Assets
1306265000
Quarters > 1 > balance Sheet > payables
34242000
Quarters > 1 > balance Sheet > short Term Debt
11766000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1147979000
Quarters > 1 > balance Sheet > equity
151286000
Quarters > 1 > cash Flow > net Income
-114951000
Quarters > 1 > cash Flow > depreciation
-11770000
Quarters > 1 > cash Flow > change In Working Capital
-21814000
Quarters > 1 > cash Flow > cash From Operations
-108273000
Quarters > 1 > cash Flow > capital Expenditures
12540000
Quarters > 1 > cash Flow > cash From Investing
71175000
Quarters > 1 > cash Flow > cash From Financing
83649000
Quarters > 1 > cash Flow > net Change In Cash
49465000
Quarters > 1 > ratios > PE
-1.1674840592077356
Quarters > 1 > ratios > PB
23.57932606024351
Quarters > 1 > ratios > ROE
-75.98257604801502
Quarters > 1 > ratios > ROA
-8.799975502673654
Quarters > 1 > ratios > FCF
-120813000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.7256210359408034
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
139292000
Quarters > 2 > income Statement > cost Of Revenue
28662000
Quarters > 2 > income Statement > gross Profit
110630000
Quarters > 2 > income Statement > operating Expenses
253569000
Quarters > 2 > income Statement > operating Income
-142939000
Quarters > 2 > income Statement > interest Expense
14342000
Quarters > 2 > income Statement > pretax Income
-149770000
Quarters > 2 > income Statement > net Income
-151080000
Quarters > 2 > income Statement > eps
-1.5690322795054246
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
96288650
Quarters > 2 > income Statement > income Tax Expense
1310000
Quarters > 2 > income Statement > EBITDA
-126438000
Quarters > 2 > income Statement > operating Margin
-102.61824081785026
Quarters > 2 > income Statement > total Other Income Expense Net
-6831000
Quarters > 2 > balance Sheet > cash
127055000
Quarters > 2 > balance Sheet > short Term Investments
367385000
Quarters > 2 > balance Sheet > receivables
98839000
Quarters > 2 > balance Sheet > inventories
46031000
Quarters > 2 > balance Sheet > total Current Assets
699155000
Quarters > 2 > balance Sheet > property Plant Equipment
260906000
Quarters > 2 > balance Sheet > total Assets
1311927000
Quarters > 2 > balance Sheet > payables
47450000
Quarters > 2 > balance Sheet > short Term Debt
10487000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1160681000
Quarters > 2 > balance Sheet > equity
144246000
Quarters > 2 > cash Flow > net Income
-151080000
Quarters > 2 > cash Flow > depreciation
8990000
Quarters > 2 > cash Flow > change In Working Capital
-56633000
Quarters > 2 > cash Flow > cash From Operations
-166475000
Quarters > 2 > cash Flow > capital Expenditures
16324000
Quarters > 2 > cash Flow > cash From Investing
119890000
Quarters > 2 > cash Flow > cash From Financing
157000
Quarters > 2 > cash Flow > net Change In Cash
-44980000
Quarters > 2 > ratios > PE
-1.5690322795054246
Quarters > 2 > ratios > PB
24.184641442397016
Quarters > 2 > ratios > ROE
-104.73773969468824
Quarters > 2 > ratios > ROA
-11.515884649069651
Quarters > 2 > ratios > FCF
-182799000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-1.312343853200471
Quarters > 2 > health Score
8
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
164877000
Quarters > 3 > income Statement > cost Of Revenue
16894000
Quarters > 3 > income Statement > gross Profit
147983000
Quarters > 3 > income Statement > operating Expenses
270261000
Quarters > 3 > income Statement > operating Income
-122278000
Quarters > 3 > income Statement > interest Expense
15522000
Quarters > 3 > income Statement > pretax Income
-133404000
Quarters > 3 > income Statement > net Income
-133385000
Quarters > 3 > income Statement > eps
-1.394052855657467
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
95681451
Quarters > 3 > income Statement > income Tax Expense
-19000
Quarters > 3 > income Statement > EBITDA
-108803000
Quarters > 3 > income Statement > operating Margin
-74.16316405562935
Quarters > 3 > income Statement > total Other Income Expense Net
-11126000
Quarters > 3 > balance Sheet > cash
173729000
Quarters > 3 > balance Sheet > short Term Investments
436296000
Quarters > 3 > balance Sheet > receivables
121801000
Quarters > 3 > balance Sheet > inventories
45007000
Quarters > 3 > balance Sheet > total Current Assets
817123000
Quarters > 3 > balance Sheet > property Plant Equipment
265929000
Quarters > 3 > balance Sheet > total Assets
1503456000
Quarters > 3 > balance Sheet > payables
38756000
Quarters > 3 > balance Sheet > short Term Debt
10297000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1241159000
Quarters > 3 > balance Sheet > equity
255297000
Quarters > 3 > cash Flow > net Income
-133385000
Quarters > 3 > cash Flow > depreciation
9079000
Quarters > 3 > cash Flow > change In Working Capital
22751000
Quarters > 3 > cash Flow > cash From Operations
-79503000
Quarters > 3 > cash Flow > capital Expenditures
654000
Quarters > 3 > cash Flow > cash From Investing
102735000
Quarters > 3 > cash Flow > cash From Financing
3186000
Quarters > 3 > cash Flow > net Change In Cash
23945000
Quarters > 3 > ratios > PE
-1.394052855657467
Quarters > 3 > ratios > PB
13.578455562462544
Quarters > 3 > ratios > ROE
-52.24699075978174
Quarters > 3 > ratios > ROA
-8.871892493029392
Quarters > 3 > ratios > FCF
-80157000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.4861624119798395
Quarters > 3 > health Score
9
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
560230000
Annuals > 0 > income Statement > cost Of Revenue
76728000
Annuals > 0 > income Statement > gross Profit
483502000
Annuals > 0 > income Statement > operating Expenses
1019475000
Annuals > 0 > income Statement > operating Income
-535973000
Annuals > 0 > income Statement > interest Expense
63041000
Annuals > 0 > income Statement > pretax Income
-567586000
Annuals > 0 > income Statement > net Income
-569183000
Annuals > 0 > income Statement > eps
-6.286667014660058
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
90538118
Annuals > 0 > income Statement > income Tax Expense
1597000
Annuals > 0 > income Statement > EBITDA
-469002000
Annuals > 0 > income Statement > operating Margin
-95.67017117969405
Annuals > 0 > income Statement > total Other Income Expense Net
-31613000
Annuals > 0 > balance Sheet > cash
173729000
Annuals > 0 > balance Sheet > short Term Investments
436296000
Annuals > 0 > balance Sheet > receivables
121801000
Annuals > 0 > balance Sheet > inventories
45007000
Annuals > 0 > balance Sheet > total Current Assets
817123000
Annuals > 0 > balance Sheet > property Plant Equipment
265929000
Annuals > 0 > balance Sheet > total Assets
1503456000
Annuals > 0 > balance Sheet > payables
38756000
Annuals > 0 > balance Sheet > short Term Debt
10297000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1241159000
Annuals > 0 > balance Sheet > equity
255297000
Annuals > 0 > cash Flow > net Income
-569183000
Annuals > 0 > cash Flow > depreciation
35543000
Annuals > 0 > cash Flow > change In Working Capital
13918000
Annuals > 0 > cash Flow > cash From Operations
-414188000
Annuals > 0 > cash Flow > capital Expenditures
7491000
Annuals > 0 > cash Flow > cash From Investing
-17768000
Annuals > 0 > cash Flow > cash From Financing
399241000
Annuals > 0 > cash Flow > net Change In Cash
-35240000
Annuals > 0 > ratios > PE
-6.286667014660058
Annuals > 0 > ratios > PB
11.869747037607178
Annuals > 0 > ratios > ROE
-222.9493491893755
Annuals > 0 > ratios > ROA
-37.85830779218015
Annuals > 0 > ratios > FCF
-421679000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.752689074130268
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
434249000
Annuals > 1 > income Statement > cost Of Revenue
45209000
Annuals > 1 > income Statement > gross Profit
389040000
Annuals > 1 > income Statement > operating Expenses
958248000
Annuals > 1 > income Statement > operating Income
-569208000
Annuals > 1 > income Statement > interest Expense
66004000
Annuals > 1 > income Statement > pretax Income
-608464000
Annuals > 1 > income Statement > net Income
-606639000
Annuals > 1 > income Statement > eps
-8.248669345104558
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
73543862
Annuals > 1 > income Statement > income Tax Expense
-1825000
Annuals > 1 > income Statement > EBITDA
-516454000
Annuals > 1 > income Statement > operating Margin
-131.07871290434753
Annuals > 1 > income Statement > total Other Income Expense Net
-39256000
Annuals > 1 > balance Sheet > cash
213584000
Annuals > 1 > balance Sheet > short Term Investments
363625000
Annuals > 1 > balance Sheet > receivables
73390000
Annuals > 1 > balance Sheet > inventories
33969000
Annuals > 1 > balance Sheet > total Current Assets
732184000
Annuals > 1 > balance Sheet > property Plant Equipment
290566000
Annuals > 1 > balance Sheet > total Assets
1491013000
Annuals > 1 > balance Sheet > payables
42114000
Annuals > 1 > balance Sheet > short Term Debt
12595000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1215599000
Annuals > 1 > balance Sheet > equity
275414000
Annuals > 1 > cash Flow > net Income
-606639000
Annuals > 1 > cash Flow > depreciation
26006000
Annuals > 1 > cash Flow > change In Working Capital
-15101000
Annuals > 1 > cash Flow > cash From Operations
-474806000
Annuals > 1 > cash Flow > capital Expenditures
46767000
Annuals > 1 > cash Flow > cash From Investing
168000000
Annuals > 1 > cash Flow > cash From Financing
388142000
Annuals > 1 > cash Flow > net Change In Cash
81798000
Annuals > 1 > ratios > PE
-8.248669345104558
Annuals > 1 > ratios > PB
8.937501583579628
Annuals > 1 > ratios > ROE
-220.2644019548752
Annuals > 1 > ratios > ROA
-40.68636557830146
Annuals > 1 > ratios > FCF
-521573000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.20109200021186
Annuals > 1 > health Score
8
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
363329000
Annuals > 2 > income Statement > cost Of Revenue
28320000
Annuals > 2 > income Statement > gross Profit
335009000
Annuals > 2 > income Statement > operating Expenses
983928000
Annuals > 2 > income Statement > operating Income
-648919000
Annuals > 2 > income Statement > interest Expense
43015000
Annuals > 2 > income Statement > pretax Income
-701725000
Annuals > 2 > income Statement > net Income
-707421000
Annuals > 2 > income Statement > eps
-10.118412955303445
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
69914225
Annuals > 2 > income Statement > income Tax Expense
5696000
Annuals > 2 > income Statement > EBITDA
-640490000
Annuals > 2 > income Statement > operating Margin
-178.60368976877706
Annuals > 2 > income Statement > total Other Income Expense Net
-52806000
Annuals > 2 > balance Sheet > cash
132944000
Annuals > 2 > balance Sheet > short Term Investments
614818000
Annuals > 2 > balance Sheet > receivables
40445000
Annuals > 2 > balance Sheet > inventories
26766000
Annuals > 2 > balance Sheet > total Current Assets
883899000
Annuals > 2 > balance Sheet > property Plant Equipment
259726000
Annuals > 2 > balance Sheet > total Assets
1545444000
Annuals > 2 > balance Sheet > payables
43274000
Annuals > 2 > balance Sheet > short Term Debt
11779000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1192950000
Annuals > 2 > balance Sheet > equity
352494000
Annuals > 2 > cash Flow > net Income
-707421000
Annuals > 2 > cash Flow > depreciation
18220000
Annuals > 2 > cash Flow > change In Working Capital
60235000
Annuals > 2 > cash Flow > cash From Operations
-380465000
Annuals > 2 > cash Flow > capital Expenditures
146123000
Annuals > 2 > cash Flow > cash From Investing
-291652000
Annuals > 2 > cash Flow > cash From Financing
501208000
Annuals > 2 > cash Flow > net Change In Cash
-171984000
Annuals > 2 > ratios > PE
-10.118412955303445
Annuals > 2 > ratios > PB
6.638493451661588
Annuals > 2 > ratios > ROE
-200.69022451445983
Annuals > 2 > ratios > ROA
-45.77461234441365
Annuals > 2 > ratios > FCF
-526588000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.4493420563731494
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
351406000
Annuals > 3 > income Statement > cost Of Revenue
16008000
Annuals > 3 > income Statement > gross Profit
335398000
Annuals > 3 > income Statement > operating Expenses
717135000
Annuals > 3 > income Statement > operating Income
-381737000
Annuals > 3 > income Statement > interest Expense
29422000
Annuals > 3 > income Statement > pretax Income
-452981000
Annuals > 3 > income Statement > net Income
-454025000
Annuals > 3 > income Statement > eps
-6.6969744617418785
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
67795540
Annuals > 3 > income Statement > income Tax Expense
1044000
Annuals > 3 > income Statement > EBITDA
-410320000
Annuals > 3 > income Statement > operating Margin
-108.63132672748901
Annuals > 3 > income Statement > total Other Income Expense Net
-71244000
Annuals > 3 > balance Sheet > cash
307584000
Annuals > 3 > balance Sheet > short Term Investments
432612000
Annuals > 3 > balance Sheet > receivables
28432000
Annuals > 3 > balance Sheet > inventories
16231000
Annuals > 3 > balance Sheet > total Current Assets
856604000
Annuals > 3 > balance Sheet > property Plant Equipment
176183000
Annuals > 3 > balance Sheet > total Assets
1522397000
Annuals > 3 > balance Sheet > payables
17138000
Annuals > 3 > balance Sheet > short Term Debt
11066000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
599836000
Annuals > 3 > balance Sheet > equity
922561000
Annuals > 3 > cash Flow > net Income
-454025000
Annuals > 3 > cash Flow > depreciation
13239000
Annuals > 3 > cash Flow > change In Working Capital
-63236000
Annuals > 3 > cash Flow > cash From Operations
-338695000
Annuals > 3 > cash Flow > capital Expenditures
73093000
Annuals > 3 > cash Flow > cash From Investing
-195372000
Annuals > 3 > cash Flow > cash From Financing
118552000
Annuals > 3 > cash Flow > net Change In Cash
-416709000
Annuals > 3 > ratios > PE
-6.6969744617418785
Annuals > 3 > ratios > PB
2.459584486879458
Annuals > 3 > ratios > ROE
-49.21354793883548
Annuals > 3 > ratios > ROA
-29.823035647074974
Annuals > 3 > ratios > FCF
-411788000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.17182973540577
Annuals > 3 > health Score
30
Valuation > metrics > PE
-1.8082655575781479
Valuation > metrics > PB
394.66257069249593
Valuation > final Score
20
Valuation > verdict
13055.4% Overvalued
Profitability > metrics > ROE
-1969.7894933714917
Profitability > metrics > ROA
-28.049023174535066
Profitability > metrics > Net Margin
-1.1280536224544029
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
128.211172530972
Risk > metrics > Interest Coverage
-12.0787390443879
Risk > final Score
-42
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.438914256722476
Liquidity > metrics > Quick Ratio
4.997513952308473
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-25
Prev Risks > 1
-34
Prev Risks > 2
-26
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:05:04.308Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.81
Earnings History > 0 > eps Estimate
-1.21
Earnings History > 0 > eps Difference
-0.6
Earnings History > 0 > surprise Percent
-49.5868
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-05
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.17
Earnings History > 1 > eps Estimate
-1.32
Earnings History > 1 > eps Difference
0.15
Earnings History > 1 > surprise Percent
11.3636
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-06
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-1.57
Earnings History > 2 > eps Estimate
-1.64
Earnings History > 2 > eps Difference
0.07
Earnings History > 2 > surprise Percent
4.2683
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-13
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-1.39
Earnings History > 3 > eps Estimate
-1.27
Earnings History > 3 > eps Difference
-0.12
Earnings History > 3 > surprise Percent
-9.4488
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-05
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.4
Earnings History > 4 > eps Estimate
-1.47
Earnings History > 4 > eps Difference
0.07
Earnings History > 4 > surprise Percent
4.7619
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-01
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.52
Earnings History > 5 > eps Estimate
-1.69
Earnings History > 5 > eps Difference
0.17
Earnings History > 5 > surprise Percent
10.0592
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-02
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-2.03
Earnings History > 6 > eps Estimate
-1.73
Earnings History > 6 > eps Difference
-0.3
Earnings History > 6 > surprise Percent
-17.341
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-15
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.52
Earnings History > 7 > eps Estimate
-1.62
Earnings History > 7 > eps Difference
0.1
Earnings History > 7 > surprise Percent
6.1728
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-02
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-2.23
Earnings History > 8 > eps Estimate
-2.08
Earnings History > 8 > eps Difference
-0.15
Earnings History > 8 > surprise Percent
-7.2115
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-2.25
Earnings History > 9 > eps Estimate
-2.07
Earnings History > 9 > eps Difference
-0.18
Earnings History > 9 > surprise Percent
-8.6957
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-2.33
Earnings History > 10 > eps Estimate
-1.98
Earnings History > 10 > eps Difference
-0.35
Earnings History > 10 > surprise Percent
-17.6768
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-16
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-2.16
Earnings History > 11 > eps Estimate
-2.14
Earnings History > 11 > eps Difference
-0.02
Earnings History > 11 > surprise Percent
-0.9346
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-02
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-3.5
Earnings History > 12 > eps Estimate
-1.81
Earnings History > 12 > eps Difference
-1.69
Earnings History > 12 > surprise Percent
-93.3702
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-07-28
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-2.26
Earnings History > 13 > eps Estimate
-1.75
Earnings History > 13 > eps Difference
-0.51
Earnings History > 13 > surprise Percent
-29.1429
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-05
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-2.19
Earnings History > 14 > eps Estimate
-1.76
Earnings History > 14 > eps Difference
-0.43
Earnings History > 14 > surprise Percent
-24.4318
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-10
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1.79
Earnings History > 15 > eps Estimate
-1.34
Earnings History > 15 > eps Difference
-0.45
Earnings History > 15 > surprise Percent
-33.5821
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-02
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.08
Earnings History > 16 > eps Estimate
-1.41
Earnings History > 16 > eps Difference
0.33
Earnings History > 16 > surprise Percent
23.4043
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-02
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-1.81
Earnings History > 17 > eps Estimate
-1.33
Earnings History > 17 > eps Difference
-0.48
Earnings History > 17 > surprise Percent
-36.0902
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-04
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-2.03
Earnings History > 18 > eps Estimate
-1.24
Earnings History > 18 > eps Difference
-0.79
Earnings History > 18 > surprise Percent
-63.7097
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-02-11
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.37
Earnings History > 19 > eps Estimate
-1.15
Earnings History > 19 > eps Difference
0.78
Earnings History > 19 > surprise Percent
67.8261
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-10-27
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.13
Earnings History > 20 > eps Estimate
-1.26
Earnings History > 20 > eps Difference
0.13
Earnings History > 20 > surprise Percent
10.3175
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-07-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0.41
Earnings History > 21 > eps Estimate
-1.54
Earnings History > 21 > eps Difference
1.95
Earnings History > 21 > surprise Percent
126.6234
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-06
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.91
Earnings History > 22 > eps Estimate
-1.68
Earnings History > 22 > eps Difference
-0.23
Earnings History > 22 > surprise Percent
-13.6905
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-02-13
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-1.62
Earnings History > 23 > eps Estimate
-1.65
Earnings History > 23 > eps Difference
0.03
Earnings History > 23 > surprise Percent
1.8182
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-05
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.96
Earnings History > 24 > eps Estimate
-1.68
Earnings History > 24 > eps Difference
-0.28
Earnings History > 24 > surprise Percent
-16.6667
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-01
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.89
Earnings History > 25 > eps Estimate
-1.7
Earnings History > 25 > eps Difference
-0.19
Earnings History > 25 > surprise Percent
-11.1765
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-06
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-1.82
Earnings History > 26 > eps Estimate
-1.74
Earnings History > 26 > eps Difference
-0.08
Earnings History > 26 > surprise Percent
-4.5977
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-02-19
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-1.73
Earnings History > 27 > eps Estimate
-1.79
Earnings History > 27 > eps Difference
0.06
Earnings History > 27 > surprise Percent
3.352
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-05
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-1.74
Earnings History > 28 > eps Estimate
-1.96
Earnings History > 28 > eps Difference
0.22
Earnings History > 28 > surprise Percent
11.2245
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-02
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-1.06
Earnings History > 29 > eps Estimate
-2.09
Earnings History > 29 > eps Difference
1.03
Earnings History > 29 > surprise Percent
49.2823
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-07
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-2.03
Earnings History > 30 > eps Estimate
-0.19
Earnings History > 30 > eps Difference
-1.84
Earnings History > 30 > surprise Percent
-968.4211
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-02-20
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-1.89
Earnings History > 31 > eps Estimate
-1.99
Earnings History > 31 > eps Difference
0.1
Earnings History > 31 > surprise Percent
5.0251
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-02
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-1.87
Earnings History > 32 > eps Estimate
-1.86
Earnings History > 32 > eps Difference
-0.01
Earnings History > 32 > surprise Percent
-0.5376
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-07-27
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
AfterMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-1.72
Earnings History > 33 > eps Estimate
-1.73
Earnings History > 33 > eps Difference
0.01
Earnings History > 33 > surprise Percent
0.578
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-04
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-1.63
Earnings History > 34 > eps Estimate
-1.71
Earnings History > 34 > eps Difference
0.08
Earnings History > 34 > surprise Percent
4.6784
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2017-02-16
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
AfterMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-1.75
Earnings History > 35 > eps Estimate
-1.72
Earnings History > 35 > eps Difference
-0.03
Earnings History > 35 > surprise Percent
-1.7442
Earnings History > 36 > period
2016-09-30
Earnings History > 36 > report Date
2016-11-07
Earnings History > 36 > date
2016-09-30
Earnings History > 36 > before After Market
AfterMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-1.64
Earnings History > 36 > eps Estimate
-1.53
Earnings History > 36 > eps Difference
-0.11
Earnings History > 36 > surprise Percent
-7.1895
Earnings History > 37 > period
2016-06-30
Earnings History > 37 > report Date
2016-08-08
Earnings History > 37 > date
2016-06-30
Earnings History > 37 > before After Market
AfterMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-1.46
Earnings History > 37 > eps Estimate
-1.44
Earnings History > 37 > eps Difference
-0.02
Earnings History > 37 > surprise Percent
-1.3889
Earnings History > 38 > period
2016-03-31
Earnings History > 38 > report Date
2016-05-09
Earnings History > 38 > date
2016-03-31
Earnings History > 38 > before After Market
AfterMarket
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-1.35
Earnings History > 38 > eps Estimate
-1.29
Earnings History > 38 > eps Difference
-0.06
Earnings History > 38 > surprise Percent
-4.6512
Earnings History > 39 > period
2015-12-31
Earnings History > 39 > report Date
2016-02-25
Earnings History > 39 > date
2015-12-31
Earnings History > 39 > before After Market
AfterMarket
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-1.42
Earnings History > 39 > eps Estimate
-1.14
Earnings History > 39 > eps Difference
-0.28
Earnings History > 39 > surprise Percent
-24.5614
Earnings History > 40 > period
2015-09-30
Earnings History > 40 > report Date
2015-11-09
Earnings History > 40 > date
2015-09-30
Earnings History > 40 > before After Market
AfterMarket
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-1.03
Earnings History > 40 > eps Estimate
-0.87
Earnings History > 40 > eps Difference
-0.16
Earnings History > 40 > surprise Percent
-18.3908
Earnings History > 41 > period
2015-06-30
Earnings History > 41 > report Date
2015-08-13
Earnings History > 41 > date
2015-06-30
Earnings History > 41 > before After Market
AfterMarket
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.83
Earnings History > 41 > eps Estimate
-0.63
Earnings History > 41 > eps Difference
-0.2
Earnings History > 41 > surprise Percent
-31.746
Earnings History > 42 > period
2015-03-31
Earnings History > 42 > report Date
2015-05-11
Earnings History > 42 > date
2015-03-31
Earnings History > 42 > before After Market
AfterMarket
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-0.63
Earnings History > 42 > eps Estimate
-0.54
Earnings History > 42 > eps Difference
-0.09
Earnings History > 42 > surprise Percent
-16.6667
Earnings History > 43 > period
2014-12-31
Earnings History > 43 > report Date
2015-03-25
Earnings History > 43 > date
2014-12-31
Earnings History > 43 > before After Market
AfterMarket
Earnings History > 43 > currency
USD
Earnings History > 43 > eps Actual
-0.52
Earnings History > 43 > eps Estimate
-0.53
Earnings History > 43 > eps Difference
0.01
Earnings History > 43 > surprise Percent
1.8868
Earnings History > 44 > period
2014-09-30
Earnings History > 44 > report Date
2014-11-10
Earnings History > 44 > date
2014-09-30
Earnings History > 44 > before After Market
BeforeMarket
Earnings History > 44 > currency
USD
Earnings History > 44 > eps Actual
-0.5
Earnings History > 44 > eps Estimate
-0.46
Earnings History > 44 > eps Difference
-0.04
Earnings History > 44 > surprise Percent
-8.6957
Earnings History > 45 > period
2014-06-30
Earnings History > 45 > report Date
2014-08-11
Earnings History > 45 > date
2014-06-30
Earnings History > 45 > before After Market
-
Earnings History > 45 > currency
USD
Earnings History > 45 > eps Actual
-0.45
Earnings History > 45 > eps Estimate
-0.42
Earnings History > 45 > eps Difference
-0.03
Earnings History > 45 > surprise Percent
-7.1429
Earnings History > 46 > period
2014-03-31
Earnings History > 46 > report Date
2014-05-12
Earnings History > 46 > date
2014-03-31
Earnings History > 46 > before After Market
-
Earnings History > 46 > currency
USD
Earnings History > 46 > eps Actual
-0.85
Earnings History > 46 > eps Estimate
-0.37
Earnings History > 46 > eps Difference
-0.48
Earnings History > 46 > surprise Percent
-129.7297
Earnings History > 47 > period
2013-12-31
Earnings History > 47 > report Date
2014-03-24
Earnings History > 47 > date
2013-12-31
Earnings History > 47 > before After Market
-
Earnings History > 47 > currency
USD
Earnings History > 47 > eps Actual
-4.98
Earnings History > 47 > eps Estimate
-0.38
Earnings History > 47 > eps Difference
-4.6
Earnings History > 47 > surprise Percent
-1210.5263
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for the treatment of long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidates that are in Phase 3 clinical trials include UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; and GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome. It also develops UX701 that is in Phase 2 clinical trial for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; GeneTx; Mereo; University of Pennsylvania; Solid Biosciences Inc.; Regeneron; Abeona; and Arcturus Therapeutics Holdings Inc. The company was incorporated in 2010 and is headquartered in Novato, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AUSA Rare Earth Stock (NASDAQ: USAR) Drops on Dec. 15, 2025: Latest News, Analyst Forecasts, and Key Catalysts Driving Volatility ts2.tech
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$81.85
Analyst Picks
Strong Buy
13
Buy
6
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 84.97% of the total shares of Ultragenyx
1.
Vanguard Group Inc(10.598%)
since
2025/06/30
2.
BlackRock Inc(6.4917%)
since
2025/06/30
3.
Sands Capital Management, LLC(4.092%)
since
2025/06/30
4.
JPMorgan Chase & Co(3.3836%)
since
2025/06/30
5.
T. Rowe Price Associates, Inc.(2.9949%)
since
2025/06/30
6.
Vanguard Total Stock Mkt Idx Inv(2.9174%)
since
2025/07/31
7.
Baker Bros Advisors LP(2.8771%)
since
2025/06/30
8.
FMR Inc(2.7026%)
since
2025/06/30
9.
State Street Corp(2.6691%)
since
2025/06/30
10.
Sands Capital Select Growth TE Inst EQ(2.4793%)
since
2025/06/30
11.
Suvretta Capital Management, LLC(2.3638%)
since
2025/06/30
12.
Vanguard Small Cap Index(2.2609%)
since
2025/07/31
13.
ClearBridge Advisors, LLC(2.2212%)
since
2025/06/30
14.
Federated Hermes Inc(2.1267%)
since
2025/06/30
15.
Vanguard Explorer Inv(2.1085%)
since
2025/06/30
16.
Wellington Management Company LLP(1.9423%)
since
2025/06/30
17.
Geode Capital Management, LLC(1.7774%)
since
2025/06/30
18.
RTW INVESTMENTS, LLC(1.7717%)
since
2025/06/30
19.
Pictet Asset Manangement SA(1.7639%)
since
2025/06/30
20.
Alkeon Capital Management, LLC(1.7492%)
since
2025/06/30
21.
Strategic Advisers Fidelity US TtlStk(1.7358%)
since
2025/07/31
22.
Deutsche Bank AG(1.7286%)
since
2025/06/30
23.
JPMorgan Mid Cap Growth I(1.7071%)
since
2025/07/31
24.
Adage Capital Partners Gp LLC(1.5871%)
since
2025/06/30
25.
BNP Paribas Investment Partners SA(1.5068%)
since
2025/06/30
26.
Alyeska Investment Group, L.P.(1.4833%)
since
2025/06/30
27.
JPM US Mid Cap Growth-Composite(1.278%)
since
2025/06/30
28.
Vanguard Small Cap Growth Index Inv(1.2767%)
since
2025/07/31
29.
DWS Vermögensbildungsfonds I LD(1.2248%)
since
2025/07/31
30.
Federated Hermes Kaufmann Small Cap A(1.1321%)
since
2025/06/30
31.
Federated Hermes Kaufmann Small Cap Grow(1.1321%)
since
2025/06/30
32.
Vanguard Institutional Extnd Mkt Idx Tr(1.0554%)
since
2025/07/31
33.
SPDR® S&P Biotech ETF(1.0276%)
since
2025/08/31
34.
Federated Hermes Kaufmann R(0.9676%)
since
2025/06/30
35.
Federated Hermes Kaufmann Growth(0.9676%)
since
2025/06/30
36.
ACAP Strategic A(0.8578%)
since
2025/06/30
37.
Vanguard Strategic Equity Inv(0.8121%)
since
2025/06/30
38.
Touchstone Sands Capital Select Growth Z(0.7727%)
since
2025/06/30
39.
Fidelity Select Biotechnology(0.7165%)
since
2025/07/31
40.
BNP Paribas Health Cr Innovtr Cl Cap(0.7064%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.81
EPS Estimate
-1.21
EPS Difference
-0.6
Surprise Percent
-49.5868%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.